Literature DB >> 12548283

Structure of Mycobacterium tuberculosis PknB supports a universal activation mechanism for Ser/Thr protein kinases.

Tracy A Young1, Benedicte Delagoutte, James A Endrizzi, Arnold M Falick, Tom Alber.   

Abstract

A family of eukaryotic-like Ser/Thr protein kinases occurs in bacteria, but little is known about the structures and functions of these proteins. Here we characterize PknB, a transmembrane signaling kinase from Mycobacterium tuberculosis. The intracellular PknB kinase domain is active autonomously, and the active enzyme is phosphorylated on residues homologous to regulatory phospho-acceptors in eukaryotic Ser/Thr kinases. The crystal structure of the PknB kinase domain in complex with an ATP analog reveals the active conformation. The predicted fold of the PknB extracellular domain matches the proposed targeting domain of penicillin-binding protein 2x. The structural and chemical similarities of PknB to metazoan homologs support a universal activation mechanism of Ser/Thr protein kinases in prokaryotes and eukaryotes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12548283     DOI: 10.1038/nsb897

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  82 in total

1.  Mycobacterium tuberculosis protein kinase K enables growth adaptation through translation control.

Authors:  Vandana Malhotra; Blessing P Okon; Josephine E Clark-Curtiss
Journal:  J Bacteriol       Date:  2012-06-01       Impact factor: 3.490

2.  Automated protein crystal structure determination using ELVES.

Authors:  James Holton; Tom Alber
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-29       Impact factor: 11.205

3.  Identification of multiple substrates of the StkP Ser/Thr protein kinase in Streptococcus pneumoniae.

Authors:  Linda Nováková; Silvia Bezousková; Petr Pompach; Petra Spidlová; Lenka Sasková; Jaroslav Weiser; Pavel Branny
Journal:  J Bacteriol       Date:  2010-05-07       Impact factor: 3.490

4.  Allosteric activation mechanism of the Mycobacterium tuberculosis receptor Ser/Thr protein kinase, PknB.

Authors:  T Noelle Lombana; Nathaniel Echols; Matthew C Good; Nathan D Thomsen; Ho-Leung Ng; Andrew E Greenstein; Arnold M Falick; David S King; Tom Alber
Journal:  Structure       Date:  2010-12-08       Impact factor: 5.006

5.  Structure of the sensor domain of Mycobacterium tuberculosis PknH receptor kinase reveals a conserved binding cleft.

Authors:  Alexandra Cavazos; Daniil M Prigozhin; Tom Alber
Journal:  J Mol Biol       Date:  2012-06-20       Impact factor: 5.469

6.  The Mycobacterium tuberculosis serine/threonine kinases PknA and PknB: substrate identification and regulation of cell shape.

Authors:  Choong-Min Kang; Derek W Abbott; Sang Tae Park; Christopher C Dascher; Lewis C Cantley; Robert N Husson
Journal:  Genes Dev       Date:  2005-06-28       Impact factor: 11.361

Review 7.  Activation of PKR: an open and shut case?

Authors:  James L Cole
Journal:  Trends Biochem Sci       Date:  2006-12-29       Impact factor: 13.807

Review 8.  Substrate and docking interactions in serine/threonine protein kinases.

Authors:  Elizabeth J Goldsmith; Radha Akella; Xiaoshan Min; Tianjun Zhou; John M Humphreys
Journal:  Chem Rev       Date:  2007-10-19       Impact factor: 60.622

9.  Mitochondrial ADCK3 employs an atypical protein kinase-like fold to enable coenzyme Q biosynthesis.

Authors:  Jonathan A Stefely; Andrew G Reidenbach; Arne Ulbrich; Krishnadev Oruganty; Brendan J Floyd; Adam Jochem; Jaclyn M Saunders; Isabel E Johnson; Catherine E Minogue; Russell L Wrobel; Grant E Barber; David Lee; Sheng Li; Natarajan Kannan; Joshua J Coon; Craig A Bingman; David J Pagliarini
Journal:  Mol Cell       Date:  2014-12-11       Impact factor: 17.970

10.  In Silico Screen and Structural Analysis Identifies Bacterial Kinase Inhibitors which Act with β-Lactams To Inhibit Mycobacterial Growth.

Authors:  Nathan Wlodarchak; Nathan Teachout; Jeffrey Beczkiewicz; Rebecca Procknow; Adam J Schaenzer; Kenneth Satyshur; Martin Pavelka; William Zuercher; David Drewry; John-Demian Sauer; Rob Striker
Journal:  Mol Pharm       Date:  2018-10-18       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.